Botanix Pharmaceuticals (BOT) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period First Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launchDecember 17, 2024 | msn.comHealth Check: Clinical trials don’t sleigh down for the silly seasonDecember 17, 2024 | msn.comBotanix Pharmaceuticals Prepares for Sofdra™ Market LaunchDecember 16, 2024 | tipranks.comAxillary Hyperhidrosis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsightDecember 12, 2024 | theglobeandmail.comThis ASX biotech stock could be the next M&A targetDecember 5, 2024 | afr.comBotanix Pharmaceuticals: Director’s Stock Interests SurgeDecember 3, 2024 | tipranks.comBotanix Pharmaceuticals Lists New Securities on ASXDecember 2, 2024 | tipranks.comThose who invested in Botanix Pharmaceuticals (ASX:BOT) three years ago are up 443%November 20, 2024 | finance.yahoo.comBotanix Pharmaceuticals to Present at Key Healthcare ConferenceNovember 19, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Expands Sofdra™ Coverage in USNovember 14, 2024 | markets.businessinsider.comBiocurious: No sweat as Botanix tackles the world’s third-biggest skin disorderNovember 13, 2024 | msn.comBotanix Pharmaceuticals Passes Key AGM ResolutionsNovember 4, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Poised for Market Impact with Sofdra LaunchNovember 3, 2024 | tipranks.comBotanix Pharmaceuticals Prepares for Sofdra LaunchOctober 28, 2024 | markets.businessinsider.comHere's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn SituationOctober 24, 2024 | finance.yahoo.comBreakeven Is Near for Botanix Pharmaceuticals Limited (ASX:BOT)September 28, 2024 | uk.finance.yahoo.comAlive and Kicking: No sweat as Botanix readies for US launch of its hyperhidrosis treatmentSeptember 17, 2024 | msn.comEvening Wrap: ASX 200 starts September on winning note as big bank rally extends, gold, uranium, and lithium stocks weakerSeptember 2, 2024 | msn.comBotanix Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 31, 2024 | finance.yahoo.comBotanix Pharmaceuticals Limited (BXPHF)July 27, 2024 | finance.yahoo.comTop performing funds: A high-conviction idea from a manager that delivered 35% in FY24July 23, 2024 | msn.comASX Growth Companies With High Insider Ownership Spotlight May 2024May 26, 2024 | finance.yahoo.comBotanix Pharmaceuticals Ltd BXPHFMay 15, 2024 | morningstar.comWe're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn RateApril 30, 2024 | finance.yahoo.comBotanix Pharmaceuticals Ltd.March 8, 2024 | wsj.comBotanix Pharmaceuticals Ltd (BOT)January 23, 2024 | investing.comIf you'd put $40,000 in this ASX healthcare stock at the start of 2023, you'd have $128,000 nowJanuary 23, 2024 | fool.com.auBotanix Pharmaceuticals Ltd BOTDecember 14, 2023 | morningstar.comBotanix Pharmaceuticals (ASX:BOT) shareholders have earned a 138% return over the last yearOctober 12, 2023 | finance.yahoo.comGuess which ASX cannabis share is crashing 36% following an FDA blowSeptember 26, 2023 | fool.com.auThis ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!September 20, 2023 | fool.com.auBotanix Pharmaceuticals Full Year 2023 Earnings: AU$0.008 loss per share (vs AU$0.014 loss in FY 2022)September 1, 2023 | finance.yahoo.comFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 12, 2023 | finanznachrichten.deWhat's Happening With Fresh Tracks Therapeutics (FRTX) SharesJuly 24, 2023 | benzinga.comWhy Fresh Tracks Therapeutics (FRTX) Shares Are SkyrocketingJuly 21, 2023 | benzinga.comBOT.AX - Botanix Pharmaceuticals LimitedJune 30, 2023 | finance.yahoo.comFresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 10, 2023 | technews.tmcnet.comFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateMarch 31, 2023 | finanznachrichten.deBotanix Pharmaceuticals (ASX:BOT) adds AU$12m to market cap in the past 7 days, though investors from five years ago are still down 47%February 20, 2023 | finance.yahoo.comWe're A Little Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn RateDecember 1, 2022 | finance.yahoo.comFresh Tracks Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 11, 2022 | ca.finance.yahoo.comInvesting in ASX cannabis sharesOctober 14, 2022 | fool.com.auRVLP RVL Pharmaceuticals plcOctober 14, 2022 | seekingalpha.comThe past three years for Botanix Pharmaceuticals (ASX:BOT) investors has not been profitableSeptember 13, 2022 | finance.yahoo.comBotanix Pharmaceuticals raising for its sweating treatmentAugust 31, 2022 | afr.comEczema Clinical Trial Pipeline Insights | DelveInsightAugust 11, 2022 | finance.yahoo.comBrickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateAugust 11, 2022 | finance.yahoo.comBotanix Pharmaceuticals LtdAugust 10, 2022 | reuters.comWhy Botanix Pharmaceuticals Ltd shares rocketed 61% higher todayJuly 23, 2022 | fool.com.auMedical Marijuana Pipeline Insights | Clinical Trials Evaluation Report 2022 | DelveInsightJuly 14, 2022 | finance.yahoo.com Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. BOT Media Mentions By Week BOT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOT News Sentiment▼-0.290.60▲Average Medical News Sentiment BOT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOT Articles This Week▼30▲BOT Articles Average Week Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:BOT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Botanix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Botanix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
